UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047334 |
|---|---|
| Receipt number | R000053813 |
| Scientific Title | The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH |
| Date of disclosure of the study information | 2022/04/01 |
| Last modified on | 2022/03/30 21:52:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH
Acronym
The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH
Scientific Title
The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH
Scientific Title:Acronym
The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH
Region
| Japan |
Condition
Condition
bladder cancer
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of the present study is to evaluate the efficacy of the reduction of residual urine volume for the recurrence of bladder cancer for the patients with BPH.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the association between the bladder cancer recurrence and the reduction of the residual urine volume
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Placebo
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
YES
Concealment
Pseudo-randomization
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
drug
Interventions/Control_2
no drug
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | < |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
*NMIBC and BPH
*Bladder cancer is diagnosed by cystoscopy or radiological findings.
*BPH is diagnosed by prostate size (>20mL) and IPSS (>7).
Key exclusion criteria
Bladder cancer with MIBC and/or distant metastasis was excluded in the present study.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Nobuhiro |
| Middle name | |
| Last name | Haga |
Organization
Fukuoka University, Faculty of Medicine
Division name
Department of Urology
Zip code
814-0180
Address
45-1, 7-chome Nanakuma, Jonan-ku,
TEL
0928011011
urology@fukuoka-u.ac.jp
Public contact
Name of contact person
| 1st name | Nobuhiro |
| Middle name | |
| Last name | Haga |
Organization
Fukuoka University, Faculty of Medicine
Division name
Department of Urology
Zip code
814-0180
Address
45-1, 7-chome Nanakuma, Jonan-ku,
TEL
0928011011
Homepage URL
urology@fukuoka-u.ac.jp
Sponsor or person
Institute
Fukuoka University, Faculty of Medicine
Institute
Department
Personal name
Funding Source
Organization
Fukuoka University, Faculty of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Fukuoka University, Faculty of Medicine
Address
45-1, 7-chome Nanakuma, Jonan-ku
Tel
0928011011
nhaga@fukuoka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2022 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2035 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 03 | Month | 30 | Day |
Last modified on
| 2022 | Year | 03 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053813
